NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Pediatric HIV Disclosure Benefits Study (PhD-BS) - Sankofa 2

CompletedNA

Sponsor: Boston University

Conditions: HIV

Interventions: Disclosure intervention, Usual Care

Countries: Ghana

The purpose of this study is to conduct a pragmatic, stepped wedge cluster randomized trial in 12 HIV pediatric clinics in Ghana to determine effectiveness, health benefits, cost and implementation to inform scale-up and sustainability of pediatric disclosure.

Eligibility overview

Sex: ALL

Age: 7 Years to 18 Years

Healthy volunteers: No

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

* HIV infected children
* Children between the ages of 7-18 who do not know their HIV diagnosis (based on caregiver account and medical records confirmation) and their caregivers will be eligible to participate in the study

Exclusion Criteria:

* HIV-infected children less than 7 years
* HIV-infected children with congenital or developmental disorders
* HIV-infected children with comorbidities such as sickle cell disease or diabetes that require frequent clinic visits or hospitalizations
* Children with AIDS-defining illness or end stage AIDS.

Locations (1)

Accra, Ghana